PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $332,000 | -31.3% | 301,633 | -14.6% | 0.00% | -50.0% |
| Q2 2020 | $483,000 | +16.9% | 353,023 | -2.7% | 0.00% | 0.0% |
| Q1 2020 | $413,000 | -32.2% | 362,650 | +35.8% | 0.00% | -33.3% |
| Q4 2019 | $609,000 | +150.6% | 267,128 | -7.4% | 0.00% | +200.0% |
| Q3 2019 | $243,000 | -33.4% | 288,336 | -22.8% | 0.00% | -50.0% |
| Q2 2019 | $365,000 | +25.9% | 373,324 | +61.7% | 0.00% | +100.0% |
| Q1 2019 | $290,000 | +133.9% | 230,878 | +350.3% | 0.00% | 0.0% |
| Q3 2018 | $124,000 | -12.1% | 51,269 | +1.3% | 0.00% | 0.0% |
| Q2 2018 | $141,000 | – | 50,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,350,000 | $36,636,000 | 4.04% |
| EcoR1 Capital, LLC | 602,315 | $9,390,000 | 2.88% |
| NEA Management Company, LLC | 3,556,778 | $55,450,000 | 2.49% |
| Opaleye Management Inc. | 152,000 | $2,370,000 | 1.24% |
| Avoro Capital Advisors LLC | 179,565 | $2,799,000 | 0.49% |
| Monashee Investment Management LLC | 85,000 | $1,325,000 | 0.47% |
| Rock Springs Capital Management LP | 450,000 | $7,016,000 | 0.44% |
| Perceptive Advisors | 344,550 | $5,372,000 | 0.35% |
| Hillhouse Capital Management | 763,790 | $11,907,000 | 0.24% |
| Eventide Asset Management | 220,000 | $3,430,000 | 0.21% |